CD24 and cancer: In this study we demonstrate that CD24+CD90+CD45− cancer cells of the MMTV- PyMT breast cancer model possess high tumorigenicity in clonogenic in vitro assays as well as in vivo upon transfer of only 100 cells into the mammary fat pad of immunodeficient mice.